Chemoinformaics analysis of 2-Methylpentadecane
| Molecular Weight | 226.448 | nRot | 12 |
| Heavy Atom Molecular Weight | 192.176 | nRig | 12 |
| Exact Molecular Weight | 226.266 | nRing | 0 |
| Solubility: LogS | -5.06 | nHRing | 0 |
| Solubility: LogP | 4.325 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 34 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
| nHA | 0 | APOL | 49.391 |
| nHD | 0 | BPOL | 34.109 |
| QED | 0.473 |
| Synth | 4.207 |
| Natural Product Likeliness | 1.555 |
| NR-PPAR-gamma | 0.852 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.997 |
| Pgp-sub | 0.005 |
| HIA | 0.005 |
| CACO-2 | -4.554 |
| MDCK | 0.0000208 |
| BBB | 0.053 |
| PPB | 0.890577 |
| VDSS | 0.677 |
| FU | 0.112399 |
| CYP1A2-inh | 0.667 |
| CYP1A2-sub | 0.552 |
| CYP2c19-inh | 0.948 |
| CYP2c19-sub | 0.779 |
| CYP2c9-inh | 0.887 |
| CYP2c9-sub | 0.162 |
| CYP2d6-inh | 0.549 |
| CYP2d6-sub | 0.168 |
| CYP3a4-inh | 0.91 |
| CYP3a4-sub | 0.613 |
| CL | 8.722 |
| T12 | 0.156 |
| hERG | 0.002 |
| Ames | 0.031 |
| ROA | 0.406 |
| SkinSen | 0.608 |
| Carcinogencity | 0.851 |
| EI | 0.024 |
| Respiratory | 0.867 |
| NR-Aromatase | 0.703 |
| Antiviral | Yes |
| Prediction | 0.674078 |